1. Home
  2. LUNG vs AHG Comparison

LUNG vs AHG Comparison

Compare LUNG & AHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • AHG
  • Stock Information
  • Founded
  • LUNG 1995
  • AHG 2013
  • Country
  • LUNG United States
  • AHG China
  • Employees
  • LUNG N/A
  • AHG N/A
  • Industry
  • LUNG Industrial Specialties
  • AHG Business Services
  • Sector
  • LUNG Health Care
  • AHG Consumer Discretionary
  • Exchange
  • LUNG Nasdaq
  • AHG Nasdaq
  • Market Cap
  • LUNG 243.2M
  • AHG 446.7M
  • IPO Year
  • LUNG 2020
  • AHG N/A
  • Fundamental
  • Price
  • LUNG $6.70
  • AHG $1.69
  • Analyst Decision
  • LUNG Buy
  • AHG
  • Analyst Count
  • LUNG 6
  • AHG 0
  • Target Price
  • LUNG $11.92
  • AHG N/A
  • AVG Volume (30 Days)
  • LUNG 241.8K
  • AHG 369.0K
  • Earning Date
  • LUNG 02-19-2025
  • AHG 01-10-2025
  • Dividend Yield
  • LUNG N/A
  • AHG N/A
  • EPS Growth
  • LUNG N/A
  • AHG N/A
  • EPS
  • LUNG N/A
  • AHG N/A
  • Revenue
  • LUNG $79,302,000.00
  • AHG $2,414,338.00
  • Revenue This Year
  • LUNG $22.26
  • AHG N/A
  • Revenue Next Year
  • LUNG $18.72
  • AHG N/A
  • P/E Ratio
  • LUNG N/A
  • AHG N/A
  • Revenue Growth
  • LUNG 22.34
  • AHG N/A
  • 52 Week Low
  • LUNG $5.46
  • AHG $0.60
  • 52 Week High
  • LUNG $14.84
  • AHG $2.90
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 56.11
  • AHG 57.65
  • Support Level
  • LUNG $6.14
  • AHG $1.11
  • Resistance Level
  • LUNG $6.93
  • AHG $1.40
  • Average True Range (ATR)
  • LUNG 0.37
  • AHG 0.28
  • MACD
  • LUNG 0.08
  • AHG 0.01
  • Stochastic Oscillator
  • LUNG 83.47
  • AHG 51.47

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About AHG Akso Health Group ADS

Akso Health Group formerly Xiaobai Maimai Inc is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.

Share on Social Networks: